Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
20948 | 378 | 33.7 | 47% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2664 | 2947 | METHYLSULFONYLMETHANE//LEUKEMIA CELL DIFFERENTIATION//N ACETYL S N METHYLCARBAMOYLCYSTEINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HEXAMETHYLENE BISACETAMIDE | Author keyword | 4 | 38% | 2% | 9 |
2 | MED SCI SLOAN KETTERING | Address | 4 | 75% | 1% | 3 |
3 | HMBA | Author keyword | 3 | 26% | 2% | 9 |
4 | MURINE ERYTHROLEUKEMIA | Author keyword | 2 | 33% | 1% | 4 |
5 | RPS5 | Author keyword | 1 | 40% | 1% | 2 |
6 | AP1 SITE | Author keyword | 1 | 50% | 0% | 1 |
7 | B1 RETROTRANSPOSON ELEMENT | Author keyword | 1 | 50% | 0% | 1 |
8 | BISACETAMIDE | Author keyword | 1 | 50% | 0% | 1 |
9 | CHINA EDUC | Address | 1 | 50% | 0% | 1 |
10 | ERYTHROCYTIC DIFFERENTIATION | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HEXAMETHYLENE BISACETAMIDE | 4 | 38% | 2% | 9 | Search HEXAMETHYLENE+BISACETAMIDE | Search HEXAMETHYLENE+BISACETAMIDE |
2 | HMBA | 3 | 26% | 2% | 9 | Search HMBA | Search HMBA |
3 | MURINE ERYTHROLEUKEMIA | 2 | 33% | 1% | 4 | Search MURINE+ERYTHROLEUKEMIA | Search MURINE+ERYTHROLEUKEMIA |
4 | RPS5 | 1 | 40% | 1% | 2 | Search RPS5 | Search RPS5 |
5 | AP1 SITE | 1 | 50% | 0% | 1 | Search AP1+SITE | Search AP1+SITE |
6 | B1 RETROTRANSPOSON ELEMENT | 1 | 50% | 0% | 1 | Search B1+RETROTRANSPOSON+ELEMENT | Search B1+RETROTRANSPOSON+ELEMENT |
7 | BISACETAMIDE | 1 | 50% | 0% | 1 | Search BISACETAMIDE | Search BISACETAMIDE |
8 | ERYTHROCYTIC DIFFERENTIATION | 1 | 50% | 0% | 1 | Search ERYTHROCYTIC+DIFFERENTIATION | Search ERYTHROCYTIC+DIFFERENTIATION |
9 | MURINE ERYTHROLEUKEMIA MEL CELLS | 1 | 50% | 0% | 1 | Search MURINE+ERYTHROLEUKEMIA+MEL+CELLS | Search MURINE+ERYTHROLEUKEMIA+MEL+CELLS |
10 | N6 SUBSTITUTED ADENOSINES | 1 | 50% | 0% | 1 | Search N6+SUBSTITUTED+ADENOSINES | Search N6+SUBSTITUTED+ADENOSINES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NSC 95580 | 8 | 100% | 1% | 5 |
2 | MEL CELLS | 7 | 57% | 2% | 8 |
3 | AGENT HEXAMETHYLENE BISACETAMIDE | 4 | 75% | 1% | 3 |
4 | INDUCER MEDIATED COMMITMENT | 1 | 100% | 1% | 2 |
5 | BISACETAMIDE | 1 | 40% | 1% | 2 |
6 | HYBRID POLAR COMPOUNDS | 1 | 18% | 1% | 5 |
7 | DIFFERENTIATING AGENT | 1 | 27% | 1% | 3 |
8 | CH33NHCUCL32H2O | 1 | 50% | 0% | 1 |
9 | N8 ACETYLSPERMIDINE DEACETYLASE | 1 | 50% | 0% | 1 |
10 | ERYTHROLEUKEMIA MEL CELLS | 0 | 33% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
HEXAMETHYLENE BISACETAMIDE-INDUCED DIFFERENTIATION OF TRANSFORMED-CELLS - MOLECULAR AND CELLULAR EFFECTS AND THERAPEUTIC APPLICATION | 1988 | 18 | 26 | 62% |
Induced differentiation, the cell cycle, and the treatment of cancer | 1996 | 39 | 48 | 21% |
Mechanisms involved in the induced differentiation of leukemia cells | 2003 | 97 | 325 | 16% |
HEXAMETHYLENE BISACETAMIDE - A POLAR-PLANAR COMPOUND ENTERING CLINICAL-TRIALS AS A DIFFERENTIATING AGENT | 1986 | 38 | 9 | 67% |
INDUCING DIFFERENTIATION OF TRANSFORMED-CELLS WITH HYBRID POLAR COMPOUNDS - A CELL CYCLE-DEPENDENT PROCESS | 1994 | 84 | 34 | 26% |
Cell cycle regulatory proteins are targets for induced differentiation of transformed cells: Molecular and clinical studies employing hybrid polar compounds | 1996 | 33 | 103 | 17% |
MOLECULAR AND CELLULAR MECHANISMS OF LEUKEMIC HEMATOPOIETIC-CELL DIFFERENTIATION - AN ANALYSIS OF THE FRIEND SYSTEM | 1985 | 32 | 55 | 58% |
INDUCED-DIFFERENTIATION OF ERYTHROLEUKEMIA-CELLS BY HEXAMETHYLENE BISACETAMIDE - A MODEL FOR CYTODIFFERENTIATION OF TRANSFORMED-CELLS | 1989 | 5 | 43 | 47% |
DIFFERENTIATION OF LEUKEMIC-CELL LINES - A REVIEW FOCUSING ON MURINE ERYTHROLEUKEMIA AND HUMAN HL-60 CELLS | 1985 | 52 | 59 | 22% |
INDUCED-DIFFERENTIATION OF MURINE ERYTHROLEUKEMIA-CELLS - CELLULAR AND MOLECULAR MECHANISMS | 1984 | 18 | 35 | 54% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED SCI SLOAN KETTERING | 4 | 75% | 0.8% | 3 |
2 | CHINA EDUC | 1 | 50% | 0.3% | 1 |
3 | MINIST CELL BIOL TUMOR CELL ENGN | 1 | 50% | 0.3% | 1 |
4 | MT SINAI BIOL SCI | 1 | 50% | 0.3% | 1 |
5 | NFKB SIGNALING HUMAN AILMENTS | 1 | 50% | 0.3% | 1 |
6 | LIFE SCI CELL BIOL | 0 | 33% | 0.3% | 1 |
7 | SCI REGULAT BIOL | 0 | 14% | 0.3% | 1 |
8 | EXPTL CELL BIOL MOLLIE B ROTH | 0 | 100% | 0.3% | 1 |
9 | HEMATOL ONCOL HEMATOL ONCOL | 0 | 100% | 0.3% | 1 |
10 | MED CANC CHEMOTHER Y FDN | 0 | 100% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000242722 | LEUKEMIA CELL DIFFERENTIATION//DUNN OSTEOSARCOMA CELLS//LOW DOSE CYTOSINE ARABINOSIDE |
2 | 0.0000222658 | SKIN ISCHEMIA//SO BUR//KRASNODAR BRANCH |
3 | 0.0000163963 | N ACETYL S N METHYLCARBAMOYLCYSTEINE//N HYDROXYMETHYL N METHYLFORMAMIDE//N METHYLFORMAMIDE |
4 | 0.0000161854 | ERYTHROID GENES//THERMOBIOL//ACLARUBICIN |
5 | 0.0000102332 | LOCUS CONTROL REGION//HEMOGLOBIN SWITCHING//EKLF |
6 | 0.0000090420 | CANCER PREVENTION EFFICACY//INVOLUCRIN EXPRESSION//CELLULAR MOL TOXICOL PROGRAM |
7 | 0.0000078244 | PAI 1 TRANSCRIPTION//MICROBIOL IMMUNOL MOL GENET A68//ANTITUMOR STUDY |
8 | 0.0000076861 | X LINKED SIDEROBLASTIC ANEMIA//ALAS2//SIDEROBLASTIC ANEMIA |
9 | 0.0000074762 | AGE RELATED PATHOLOGY//TACT EW//HERZ KREISLAUFZENTRUM D DEN |
10 | 0.0000071984 | ERYTHROPOIETIN RECEPTOR//STEM PROGENITOR CELL BIOL PROGRAM//ERYTHROBLAST MACROPHAGE PROTEIN |